Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Moon Surgical is a robotics company founded 2019, based in France, developing 1 robot primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
Moon Surgical has raised US$86.7M across 2 confirmed rounds and has no deployment evidence on file.
Raised
US$86.7M
across 2 confirmed rounds · latest May 2023
- May 2023· US$55.4M· investors: Sofinnova Partners, Nvidia's NVentures, Dr. Fred Moll +9 more· MassDevice ↗· 3 outletsCorrect this round
- Jun 2022· Series A· US$31.3M· investors: GT Healthcare Capital & Partners, Johnson & Johnson Innovation – JJDC, Cathay Health +5 more· MassDevice ↗· 2 outletsCorrect this round
Confirmed rounds recorded from January 2017. Every amount links to its source.
Correct this →Shipped
No deployment evidence on file
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Moon Surgical.
In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.
Add a deployment →Collaborative surgical robotics for minimally invasive procedures
Moon Surgical is a French-American surgical robotics company based in Paris that develops the Maestro System, a collaborative robotic surgical assistant for minimally invasive procedures. Its system is designed to help surgeons hold and manipulate tissues during laparoscopic operations, with commercialization milestones including FDA 510(k) clearance and CE marking. The company operates in France and the United States and targets hospitals and surgical teams.
Active products
1
RoboIndex
49.91
RoboScore 49.53 + Momentum 0.38
Company facts
- HQ
- Paris, France
- Founded
- 2019 · 7 yrs
- Stage
- Series A (2021)
- Website
- www.moonsurgical.com
RoboScore
49.53 RoboScore + 0.38 Momentum· Adequate evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
On the company boards
- #27 of 39·Surgical / Medical·best robot 48.80 + depth 0.00 + news 0.38 = total 49.18
A board total ranks makers within one category. It is built from the best robot's RoboScore, a capped credit for more ranked robots, and news. It is not this company's RoboIndex above. How boards work
Milestones
Moon Surgical announced CE Mark for the commercial Maestro System.
Moon Surgical received FDA 510(k) clearance for the Maestro surgical robotics system.
Moon Surgical was founded in Paris by Pr. Brice Gayet.
Press coverage
- Moon Surgical Announces CE Mark for Its Commercial Maestro System
Business Wire · Sep 2023
- Moon Surgical Maestro Surgical Robotics System
SAGES
- Moon Surgical raises $31.3M for Maestro robotic system
Sofinnova Partners
In the news
1 event · last 90 days
+0.38momentumof 15 maxMoon Surgical, Karl Storz collab on surgical robotics, visualization tech
In the news
1 event · last 90 days
Why Moon Surgical has been in the news, across 1 outlet — collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore — the evidence half of the RoboIndex — and it can move a robot up a board by at most 15 points.
Public loss record
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Active products by Moon Surgical
1 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 | Maestro System | Surgical / Medical | 2023 | 48.8 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…